# ProFibrix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/profibrix

- Industry: Biotechnology
- Headquarters: Leiden, Netherlands
- Website: www.profibrix.com
- Total disclosed funding: $22M
- Latest round: Series B (May 3, 2011)
- Investors on record: 4

## About

Established in 2004 and based in Netherlands, ProFibrix is a biotechnology company that offers products and services for the hemostasis and regnerative pharmaceutical market.

## Funding rounds

- Series B, May 3, 2011 — Index Ventures, Gilde Healthcare, Vesalius Biocapital, Inkef
- Series B, Aug 24, 2009, $11M — Index Ventures, Gilde Healthcare
- Series A, Mar 26, 2007, $11M — Index Ventures

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Series A, Series B
- Gilde Healthcare (https://capitalatlas.ai/funds/gilde-healthcare) — Series B
- Vesalius Biocapital (https://capitalatlas.ai/funds/vesalius-biocapital) — Series B
- Inkef (https://capitalatlas.ai/funds/inkef) — Series B